Trademark: 88103229
Word
QTORIN
Status
Dead
Status Code
606
Status Date
Monday, December 23, 2019
Serial Number
88103229
Mark Type
4000
Filing Date
Tuesday, September 4, 2018
Published for Opposition
Tuesday, March 26, 2019
Abandoned Date
Monday, December 23, 2019

Trademark Owner History
Palvella Therapeutics, Inc. - Owner At Publication

Classifications
5 Chemical drug delivery agent in the form of a semi-solid dissolvable medical gel that facilitates the delivery of rapamycin by enabling and facilitating the placement of agents that act on mammalian targets for the delivery of rapamycin in and on the skin
39 Delivery of goods, namely, delivery of chemical delivery systems for a medical topical gel application

Trademark Events
Dec 23, 2019
Abandonment Notice E-Mailed - No Use Statement Filed
Dec 23, 2019
Abandonment - No Use Statement Filed
May 21, 2019
Noa E-Mailed - Sou Required From Applicant
Mar 26, 2019
Official Gazette Publication Confirmation E-Mailed
Mar 26, 2019
Published For Opposition
Mar 6, 2019
Notification Of Notice Of Publication E-Mailed
Feb 11, 2019
Approved For Pub - Principal Register
Feb 11, 2019
Examiner's Amendment Entered
Feb 8, 2019
Notification Of Examiners Amendment E-Mailed
Feb 8, 2019
Examiners Amendment E-Mailed
Feb 8, 2019
Examiners Amendment -Written
Feb 7, 2019
Previous Allowance Count Withdrawn
Jan 29, 2019
Withdrawn From Pub - Og Review Query
Jan 14, 2019
Approved For Pub - Principal Register
Jan 14, 2019
Examiner's Amendment Entered
Jan 14, 2019
Assigned To Lie
Jan 14, 2019
Notification Of Examiners Amendment E-Mailed
Jan 14, 2019
Examiners Amendment E-Mailed
Jan 14, 2019
Examiners Amendment -Written
Dec 28, 2018
Notification Of Non-Final Action E-Mailed
Dec 28, 2018
Non-Final Action E-Mailed
Dec 28, 2018
Non-Final Action Written
Dec 15, 2018
Assigned To Examiner
Sep 11, 2018
New Application Office Supplied Data Entered In Tram
Sep 7, 2018
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24